Felicia Forma, BSc

home / authors / felicia-forma-bsc

Articles

Site Logo
May 16th 2017

The Cost of Adherence Mismeasurement in Serious Mental Illness: A Claims-Based Analysis

Jason Shafrin, PhD Felicia Forma, BSc Ethan Scherer, PhD Ainslie Hatch, PhD Edward Vytlacil, PhD Darius Lakdawalla, PhD

This study demonstrates that common pharmacy claims-based measures underestimate the effect of actual adherence on inpatient costs among patients with serious mental illness.

Site Logo
September 30th 2013

Improving Patient-Centered Care in Diabetes With Comparative Effectiveness Research

Douglas K. Owens, MD Wade Aubry, MD Roy Beck, MD Joshua Benner, MD Jan E. Berger, PharmD Michael E. Chernew, PhD Felicia Forma, BSc Dana P. Goldman, PhD William H. Herman, MD Rebecca Killion, MA Darius Lakdawalla, PhD Anne L Peters, MD

Site Logo
July 2nd 2013

Comparative Effectiveness Research and Formulary Placement: The Case of Diabetes

Michael E. Chernew, PhD Rick McKellar, BS Wade Aubry, MD Roy Beck, MD, PhD Joshua Benner, PharmD, ScD Jan E. Berger, MD, MJ A. Mark Fendrick, MD Felicia Forma, BSc Dana Goldman, PhD Anne Peters, MD Rebecca Killion, MA Darius Lakdawalla, PhD Douglas K. Owens, MD Joe Stahl, MA

Site Logo
February 12th 2013

Comparative Effectiveness Research and Formulary Placement: The Case of Diabetes

Michael E. Chernew, PhD Rick McKellar, BS Wade Aubry, MD Roy Beck, MD, PhD Joshua Benner, PharmD, ScD Jan E. Berger, MD, MJ A. Mark Fendrick, MD Felicia Forma, BSc Dana Goldman, PhD Anne Peters, MD Rebecca Killion, MA Darius Lakdawalla, PhD Douglas K. Owens, MD Joe Stahl, MA

Formularies of the future should use evidence-produced CER to better target, not limit, diabetes care.

Site Logo
August 11th 2010

Cost Sharing, Adherence, and Health Outcomes in Patients With Diabetes

Teresa B. Gibson, PhD Xue Song, PhD Berhanu Alemayehu, DrPH Sara S. Wang, PhD Jessica L. Waddell, MPH Jonathan R. Bouchard, MS, RPh Felicia Forma, BSc

Higher cost-sharing levels reduced adherence to antidiabetic medications in patients with type 2 diabetes.

Latest Updated Articles

FDA approval stamp | Image Credit: Surendra - stock.adobe.com
Published: November 15th 2024 | Updated: November 19th 2024
FDA Approves Revumenib for R/R Acute Leukemia With a KMT2A Translocation
What We’re Reading: Concierge Nonprofit Hospitals; Kaiser Permanente Program for Elderly Care; Health Care Not a Top Issue Among Voters
Published: April 1st 2024 | Updated: November 5th 2024
What We're Reading: Concierge Nonprofit Hospitals; Kaiser Permanente Elderly Care Program; Health Care Not Among Top Voter Issues
Clinician giving patient a diagnosis | Image Credit: Pcess609 - stock.adobe.com
Published: October 21st 2024 | Updated: October 24th 2024
Lower Diagnostic Error Rates Found Among Hospitalized Patients During Care Transitions
Hurricane | Image credit: Satoshi Kina - stock.adobe.com
Published: September 26th 2024 | Updated: October 1st 2024
Addressing Natural Disaster Takes Cooperation, Preparation to Ensure Patient Health
Opdivo packaging | Image credit: Bristol Myers Squibb
Published: May 9th 2024 | Updated: May 21st 2024
FDA Accepts Nivolumab Subcutaneous Injection Application, With Potential to Boost Access to PD-1 Inhibitors
ICYMI: Highlights From IMS 2024
Published: December 17th 2024 | Updated: December 21st 2024
ICYMI: Highlights From IMS 2024

2 Commerce Drive
Suite 100
Cranbury, NJ 08512

© 2024 MJH Life Sciences® and AJMC®.
All rights reserved.

About
Contact
Editorial Boards
Advertise
Do Not Sell My Information
Terms & Conditions
Privacy Policy
AJMC Managed Markets Network Logo
CH LogoCenter for Biosimilars Logo